FDA Approves Hikma's Generic Vascepa Amid Fed. Circ. Fight
Hikma Pharmaceuticals on Friday announced that the U.S. Food and Drug Administration has approved its generic version of Amarin Pharma Inc.'s heart drug Vascepa, amid the companies' ongoing patent battle at...To view the full article, register now.
Already a subscriber? Click here to view full article